Pharmacogenetics in the Treatment of Pre-Eclampsia: Current Findings, Challenges and Perspectives
Pre-eclampsia (PE) is defined as pregnancy-induced hypertension and proteinuria, and is a major cause of maternal and perinatal morbidity and mortality. A large subgroup of pregnant women with PE is nonresponsive to antihypertensive drugs, including methyldopa, nifedipine and hydralazine. Pharmacoge...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Revisão |
| שפה: | אנגלית |
| יצא לאור: |
2017
|
| גישה מקוונת: | https://doi.org/10.2217/pgs-2016-0198 https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0198 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|